This study uncovered that SOCS2 negatively regulated activation of the JAK/STAT pathway in HCC cells and miR-196a or miR-196b inhibition decreased HCC progression by regulating the SOCS2/JAK/STAT pathway revealed by a xenograft model. Here, SOCS2 is linked to hepatocellular carcinoma.